Dmitry Balyasny’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.69M | Buy |
+35,892
| New | +$5.34M | 0.01% | 1317 |
|
|
2026
Q1 | – | Sell |
-21,444
| Closed | -$3.31M | – | 3630 |
|
|
2025
Q4 | $3.32M | Sell |
21,444
-21,568
| -50% | -$3.23M | ﹤0.01% | 1607 |
|
|
2025
Q3 | $5.99M | Sell |
43,012
-108,698
| -72% | -$14.7M | 0.01% | 1289 |
|
|
2025
Q2 | $20.4M | Buy |
151,710
+20,581
| +16% | +$2.78M | 0.03% | 662 |
|
|
2025
Q1 | $19.1M | Sell |
131,129
-131,487
| -50% | -$19.1M | 0.03% | 615 |
|
|
2024
Q4 | $36.1M | Buy |
262,616
+260,591
| +12,869% | +$38.1M | 0.05% | 432 |
|
|
2024
Q3 | $312K | Sell |
2,025
-22,046
| -92% | -$3.34M | ﹤0.01% | 2444 |
|
|
2024
Q2 | $3.51M | Buy |
+24,071
| New | +$3.45M | 0.01% | 1325 |
|
|
2023
Q4 | – | Sell |
-82,839
| Closed | -$10.8M | – | 2968 |
|
|
2023
Q3 | $10.7M | Sell |
82,839
-20,399
| -20% | -$2.71M | 0.02% | 826 |
|
|
2023
Q2 | $13.7M | Sell |
103,238
-323,757
| -76% | -$42.7M | 0.03% | 655 |
|
|
2023
Q1 | $55.3M | Buy |
+426,995
| New | +$55.8M | 0.14% | 191 |
|
|
2022
Q3 | – | Sell |
-26,148
| Closed | -$3.37M | – | 3308 |
|
|
2022
Q2 | $3.35M | Sell |
26,148
-32,078
| -55% | -$4.2M | 0.01% | 1120 |
|
|
2022
Q1 | $7.98M | Sell |
58,226
-297,236
| -84% | -$39.4M | 0.03% | 774 |
|
|
2021
Q4 | $50.1M | Buy |
355,462
+326,155
| +1,113% | +$43.3M | 0.17% | 134 |
|
|
2021
Q3 | $3.73M | Buy |
+29,307
| New | +$3.87M | 0.02% | 923 |
|
|
2020
Q2 | – | Sell |
-253,791
| Closed | -$22.5M | – | 1540 |
|
|
2020
Q1 | $22.5M | Buy |
+253,791
| New | +$24.7M | 0.27% | 102 |
|
|
2019
Q2 | – | Sell |
-191,152
| Closed | -$17.2M | – | 1770 |
|
|
2019
Q1 | $17.5M | Buy |
191,152
+75,116
| +65% | +$6.77M | 0.12% | 252 |
|
|
2018
Q4 | $10M | Sell |
116,036
-42,142
| -27% | -$3.81M | 0.07% | 359 |
|
|
2018
Q3 | $15.1M | Buy |
+158,178
| New | +$14.3M | 0.07% | 367 |
|
|
2018
Q1 | – | Sell |
-124,290
| Closed | -$10.3M | – | 2371 |
|
|
2017
Q4 | $10.3M | Sell |
124,290
-317,209
| -72% | -$26.2M | 0.03% | 639 |
|
|
2017
Q3 | $36.1M | Buy |
+441,499
| New | +$35.5M | 0.14% | 199 |
|
|
2017
Q1 | – | Sell |
-200,000
| Closed | -$13.8M | – | 1821 |
|
|
2016
Q4 | $13.8M | Buy |
+200,000
| New | +$13.9M | 0.07% | 379 |
|
|
2016
Q3 | – | Sell |
-300,000
| Closed | -$21.5M | – | 1308 |
|
|
2016
Q2 | $21.5M | Buy |
+300,000
| New | +$21.1M | 0.14% | 194 |
|
|
2013
Q4 | – | Sell |
-310,387
| Closed | -$15.7M | – | 658 |
|
|
2013
Q3 | $15.7M | Buy |
310,387
+122,152
| +65% | +$6.14M | 0.21% | 122 |
|
|
2013
Q2 | $8.96M | Buy |
+188,235
| New | +$9.02M | 0.15% | 166 |
|
Other funds holding XLV
HIIFS
Dmitry Balyasny's XLV Position: Q2 2026 in Review
Dmitry Balyasny opened a new position in State Street Health Care Select Sector SPDR ETF (XLV) in Q2 2026: 35,892 shares worth $5.69M. The stake represents 0.01% of the portfolio and ranks #1317 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in XLV as recently as Q4 2025.
Dmitry Balyasny first reported a position in XLV in Q2 2013 and has held it in 25 quarters since. The position peaked at $55.3M in Q1 2023. 1,850 funds tracked by Wall St. Rank hold XLV as of Q2 2026.
- Dmitry Balyasny held 35,892 shares of State Street Health Care Select Sector SPDR ETF worth $5.69M as of Q2 2026.
- State Street Health Care Select Sector SPDR ETF was a new Dmitry Balyasny position in Q2 2026.
- State Street Health Care Select Sector SPDR ETF made up 0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #1317 holding.
- Dmitry Balyasny first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2013 and has held it in 25 quarters since.
- Dmitry Balyasny's State Street Health Care Select Sector SPDR ETF position peaked at $55.3M in Q1 2023.
- 1,850 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.